Clinical trial
Objective Study in Rheumatoid Arthritis
NCT00451971 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00451971 |
|---|---|
| Title | Objective Study in Rheumatoid Arthritis |
| Official title | Objective Study in Rheumatoid Arthritis |
| Acronym | OSRA |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Arthritis, Rheumatoid |
| Intervention type | Drug |
| Interventions | LEFLUNOMIDE |
| Enrollment | 249 |
| Start date | Mar 1, 2002 |
| First posted | Mar 26, 2007 |
| Last update posted | Sep 5, 2008 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: